162 related articles for article (PubMed ID: 28960353)
1. Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct-acting antiviral agents.
Ciancio A; Bosio R; Bo S; Pellegrini M; Sacco M; Vogliotti E; Fassio G; Bianco Mauthe Degerfeld AGF; Gallo M; Giordanino C; Terzi di Bergamo L; Ribaldone D; Bugianesi E; Smedile A; Rizzetto M; Saracco GM
J Med Virol; 2018 Feb; 90(2):320-327. PubMed ID: 28960353
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Glycated Haemoglobin (HbA1c) Level in Type 2 Diabetic Chronic HCV Non-cirrhotic Treatment-Naïve Egyptian Patients Eradicated with Sofosbuvir Plus Daclatasvir.
Hussein HA; Allam AS; Moaty ASA
Curr Diabetes Rev; 2020; 16(2):165-170. PubMed ID: 31146663
[TBL] [Abstract][Full Text] [Related]
3. Impact of sustained virologic response on glucose parameters among patients with chronic hepatitis C treated with direct-acting antivirals.
Benetti F; de Araújo A; de Maman Júnior I; Coelho Borges Cheinquer C; Herz Wolff F; Cheinquer H
Arch Endocrinol Metab; 2024 May; 68():e220480. PubMed ID: 38709148
[TBL] [Abstract][Full Text] [Related]
4. Effect of direct acting antiviral therapy of Chronic Hepatitis C virus on insulin resistance and Type2 DM in Egyptian patients (prospective study).
Boraie MB; Elnaggar YA; Ahmed MO; Mahmoud AM
Diabetes Metab Syndr; 2019; 13(4):2641-2646. PubMed ID: 31405688
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Hepatitis C Virus and Long-Term Effect on Glycemic Control.
Andres J; Barros M; Arutunian M; Zhao H
J Manag Care Spec Pharm; 2020 Jun; 26(6):775-781. PubMed ID: 32463777
[TBL] [Abstract][Full Text] [Related]
6. The impact of a successful treatment of hepatitis C virus on glyco-metabolic control in diabetic patients: a systematic review and meta-analysis.
Carnovale C; Pozzi M; Dassano A; D'Addio F; Gentili M; Magni C; Clementi E; Radice S; Fiorina P
Acta Diabetol; 2019 Mar; 56(3):341-354. PubMed ID: 30478781
[TBL] [Abstract][Full Text] [Related]
7. Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents.
Pavone P; Tieghi T; d'Ettorre G; Lichtner M; Marocco R; Mezzaroma I; Passavanti G; Vittozzi P; Mastroianni CM; Vullo V
Clin Microbiol Infect; 2016 May; 22(5):462.e1-3. PubMed ID: 26812446
[TBL] [Abstract][Full Text] [Related]
8. Improvement of glycemic state among responders to Sofosbuvir-based treatment regimens: Single center experience.
Abdel Alem S; Elsharkawy A; Fouad R; Adel E; Abdellatif Z; Musa S; Nagy A; Hussein MS; Yosry A; Esmat G
J Med Virol; 2017 Dec; 89(12):2181-2187. PubMed ID: 28688190
[TBL] [Abstract][Full Text] [Related]
9. Improvement in Glycemic Control of Type 2 Diabetes After Successful Treatment of Hepatitis C Virus.
Hum J; Jou JH; Green PK; Berry K; Lundblad J; Hettinger BD; Chang M; Ioannou GN
Diabetes Care; 2017 Sep; 40(9):1173-1180. PubMed ID: 28659309
[TBL] [Abstract][Full Text] [Related]
10. INSULIN RESISTANCE REDUCTION AFTER SUSTAINED VIROLOGICAL RESPONSE WITH DIRECT ACTING ANTIVIRAL:NOT EVERY POPULATION IMPROVES.
Andrade VG; Yamashiro FDS; Oliveira CV; Moreira A; Winckler FC; Silva GF
Arq Gastroenterol; 2018; 55(3):274-278. PubMed ID: 30540091
[TBL] [Abstract][Full Text] [Related]
11. Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis.
Cacciola I; Russo G; Filomia R; Pitrone C; Caccamo G; Giandalia A; Alibrandi A; Stella Franzè M; Porcari S; Maimone S; Saitta C; Squadrito G; Raimondo G
Liver Int; 2021 Sep; 41(9):2059-2067. PubMed ID: 33894103
[TBL] [Abstract][Full Text] [Related]
12. Effect of treatment with direct antiviral agents (DAAs) on glycemic control in patients with type 2 diabetes mellitus & hepatitis C virus genotype 4.
Zied HY; Abo Alnasr NM; El-Bendary AS; Abd-Elsalam S; Hagag RY
Diabetes Metab Syndr; 2020; 14(4):679-682. PubMed ID: 32438332
[TBL] [Abstract][Full Text] [Related]
13. Sustained virological response does not improve long-term glycaemic control in patients with type 2 diabetes and chronic hepatitis C.
Li J; Gordon SC; Rupp LB; Zhang T; Trudeau S; Holmberg SD; Moorman AC; Spradling PR; Teshale EH; Boscarino JA; Schmidt MA; Daida YG; Lu M;
Liver Int; 2019 Jun; 39(6):1027-1032. PubMed ID: 30570808
[TBL] [Abstract][Full Text] [Related]
14. No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV.
Chaudhury CS; Sheehan J; Chairez C; Akoth E; Gross C; Silk R; Kattakuzhy S; Rosenthal E; Kottilil S; Masur H; Hadigan C
J Infect Dis; 2017 Dec; 217(1):47-50. PubMed ID: 29161418
[TBL] [Abstract][Full Text] [Related]
15. Direct-acting antiviral agents decrease haemoglobin A1c level in patients with diabetes infected with hepatitis C virus: A systematic review & meta-analysis.
Lapumnuaypol K; Pisarcik D; Putthapiban P; Sukhumthammarat W; Wijarnpreecha K; Thongprayoon C; Ungprasert P
Indian J Med Res; 2020 Dec; 152(6):562-567. PubMed ID: 34145095
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of diabetic and non-diabetic patients with chronic hepatitis C successfully treated with direct-acting antiviral agents.
Ciancio A; Ribaldone DG; Dotta A; Giordanino C; Sacco M; Fagoonee S; Pellicano R; Saracco GM
Liver Int; 2021 Feb; 41(2):276-287. PubMed ID: 32998174
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C Virus Eradication with New Interferon-Free Treatment Improves Metabolic Profile in Hepatitis C Virus-Related Liver Transplant Recipients.
Beig J; Orr D; Harrison B; Gane E
Liver Transpl; 2018 Aug; 24(8):1031-1039. PubMed ID: 29577581
[TBL] [Abstract][Full Text] [Related]
18. Virus Elimination by Direct-Acting Antiviral Agents Impacts Glucose Homeostasis in Chronic Hepatitis C Patients.
Cheng CH; Chu CY; Chen HL; Lin IT; Wu CH; Lee YK; Bair MJ
Front Endocrinol (Lausanne); 2021; 12():799382. PubMed ID: 35095765
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus eradication with direct-acting antiviral improves insulin resistance.
Russo FP; Zanetto A; Gambato M; Bortoluzzi I; Al Zoairy R; Franceschet E; De Marchi F; Marzi L; Lynch EN; Floreani A; Farinati F; Schaefer B; Burra P; Zoller H; Mega A
J Viral Hepat; 2020 Feb; 27(2):188-194. PubMed ID: 31596996
[TBL] [Abstract][Full Text] [Related]
20. Metabolic, renal, and hematological changes in chronic hepatitis C patients achieving rapid virologic response after 12 weeks of direct-acting antiviral treatment: A prospective cohort study.
Thi Thu PN; Hoang Van D; Ngo Thi Quynh M; Tran Thi N; Pham Minh K; Pham Van L
PLoS One; 2023; 18(9):e0290235. PubMed ID: 37656689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
